Logo image of CRML

CRITICAL METALS CORP (CRML) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CRML - VGG2662B1031 - Common Stock

10.33 USD
+0.58 (+5.95%)
Last: 12/9/2025, 8:00:00 PM
10.3192 USD
-0.01 (-0.1%)
After Hours: 12/9/2025, 8:00:00 PM
Fundamental Rating

1

Taking everything into account, CRML scores 1 out of 10 in our fundamental rating. CRML was compared to 155 industry peers in the Metals & Mining industry. CRML may be in some trouble as it scores bad on both profitability and health. CRML is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CRML has reported negative net income.
In the past year CRML has reported a negative cash flow from operations.
CRML Yearly Net Income VS EBIT VS OCF VS FCFCRML Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -500K -1M -1.5M -2M

1.2 Ratios

CRML's Return On Assets of -20.02% is on the low side compared to the rest of the industry. CRML is outperformed by 80.00% of its industry peers.
With a Return On Equity value of -22.62%, CRML is not doing good in the industry: 72.26% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -20.02%
ROE -22.62%
ROIC N/A
ROA(3y)-0.18%
ROA(5y)N/A
ROE(3y)-0.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRML Yearly ROA, ROE, ROICCRML Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -0.2 -0.4 -0.6 -0.8 -1

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CRML so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRML Yearly Profit, Operating, Gross MarginsCRML Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, CRML has about the same amount of shares outstanding.
CRML has a better debt/assets ratio than last year.
CRML Yearly Shares OutstandingCRML Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M
CRML Yearly Total Debt VS Total AssetsCRML Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

CRML has an Altman-Z score of 148.55. This indicates that CRML is financially healthy and has little risk of bankruptcy at the moment.
CRML has a better Altman-Z score (148.55) than 96.77% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CRML is not too dependend on debt financing.
CRML has a better Debt to Equity ratio (0.00) than 81.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 148.55
ROIC/WACCN/A
WACCN/A
CRML Yearly LT Debt VS Equity VS FCFCRML Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

CRML has a Current Ratio of 0.08. This is a bad value and indicates that CRML is not financially healthy enough and could expect problems in meeting its short term obligations.
CRML has a Current ratio of 0.08. This is amonst the worse of the industry: CRML underperforms 96.13% of its industry peers.
A Quick Ratio of 0.08 indicates that CRML may have some problems paying its short term obligations.
CRML has a worse Quick ratio (0.08) than 96.13% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
CRML Yearly Current Assets VS Current LiabilitesCRML Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 500K 1M 1.5M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for CRML have decreased strongly by -16.60% in the last year.
EPS 1Y (TTM)-16.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.75%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 48.61% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3Y-112.7%
EPS Next 5Y48.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRML Yearly Revenue VS EstimatesCRML Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 20M 40M 60M 80M 100M
CRML Yearly EPS VS EstimatesCRML Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 0 0.05 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRML. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRML Price Earnings VS Forward Price EarningsCRML Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRML Per share dataCRML EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

A cheap valuation may be justified as CRML's earnings are expected to decrease with -112.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3Y-112.7%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRML!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CRITICAL METALS CORP

NASDAQ:CRML (12/9/2025, 8:00:00 PM)

After market: 10.3192 -0.01 (-0.1%)

10.33

+0.58 (+5.95%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners10.98%
Inst Owner Change4.89%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.09B
Revenue(TTM)N/A
Net Income(TTM)-7.24M
Analysts82.86
Price Target14.28 (38.24%)
Short Float %28.85%
Short Ratio0.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 33.91
P/tB 33.91
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.3
TBVpS0.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.02%
ROE -22.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.18%
ROA(5y)N/A
ROE(3y)-0.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z 148.55
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3Y-112.7%
EPS Next 5Y48.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y-85.91%
EBIT Next 5Y79.37%
FCF growth 1Y-563.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-188.18%
OCF growth 3YN/A
OCF growth 5YN/A

CRITICAL METALS CORP / CRML FAQ

What is the fundamental rating for CRML stock?

ChartMill assigns a fundamental rating of 1 / 10 to CRML.


What is the valuation status for CRML stock?

ChartMill assigns a valuation rating of 0 / 10 to CRITICAL METALS CORP (CRML). This can be considered as Overvalued.


What is the profitability of CRML stock?

CRITICAL METALS CORP (CRML) has a profitability rating of 0 / 10.